Microbiology & Infectious Diseases

Higher rifampicin exposure accelerated bacillary clearance and predicted pulmonary tuberculosis treatment outcomes in patients.

A recent study has demonstrated the high efficacy and favorable safety profile of sofosbuvir-based regimens in treating hepatitis C virus (HCV) in children aged 5 to 17 years.

RSV immunization in infants is safe and produces high antibody levels, regardless of whether mothers received vaccination during pregnancy.

A new study presented at IDWeek 2025 suggests that HIV preventive treatment with lenacapavir could be produced for as little as $25 per patient per year.

RSV vaccine effectiveness in older adults reached high levels against acute respiratory illness in 2023–2024 postlicensure testing.

Prior zoster vaccination reduces risks of cardiovascular events, dementia, and death after shingles infection, new IDWeek 2025 data show.

A 25-year USA study finds C. diff deaths highest among White people, women, and city residents, though overall mortality has fallen since 2015.

Invasive Aeromonas infections were uncommon yet severe in a four-year rural U.S. review of cases.